Skip to main content
OpenTrials

Clinical trial condition

Unspecified Adult Solid Tumor, Protocol Specific

Explore clinical trials studying Unspecified Adult Solid Tumor, Protocol Specific. Study availability and eligibility vary by location and protocol.

616 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Unspecified Adult Solid Tumor, Protocol Specific trial results

Completed

Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine

NCT00608933

Conditions
Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
Locations
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Melatonin and Radiation Therapy in Treating Patients With Brain Metastases

NCT00031967

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +14 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Comprehensive Cancer Institute of Huntsville Huntsville, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • Alabama Oncology, LLC Montgomery, Alabama, United States
View all 234 locations
View Trial Details
Completed

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

NCT00553059

Conditions
Chemotherapy-induced Nausea and Vomiting, Nausea, Pathological Conditions, Signs and Symptoms, +4 more
Locations
  • Cancer Research for the Ozarks Springfield, Missouri, United States
  • CCOP - Greenville Greenville, South Carolina, United States
  • University of Texas M.D. Anderson Houston, Texas, United States
  • Vermont Cancer Center at University of Vermont Burlington, Vermont, United States
View Trial Details
Completed

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

NCT01337765

Conditions
Breast Diseases, Breast Neoplasms, Digestive System Diseases, +12 more
Locations
  • Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States
  • University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston, Texas, United States
  • Pfizer Investigative Site Parkville, Victoria, Australia
  • Pfizer Investigative Site Toronto, Ontario, Canada
View Trial Details

Related conditions